FDA Inspection 1040896 — Deborah K. Armstrong, MD

Deborah K. Armstrong, MD — FEI 3013976830

The FDA completed an inspection of Deborah K. Armstrong, MD on Jan 25, 2018 in Baltimore, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jan 25, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Baltimore, MD (United States)

Additional Details

Clinical Investigator (CI)